Stool transplant for older adults with heart failure
Part of Heart & circulation clinical trials.
This trial tests whether a stool transplant, which introduces healthy bacteria into the gut, can improve symptoms and quality of life in older adults with a type of heart failure where the heart's pumping function is preserved but filling is impaired. It may help because the gut bacteria can affect inflammation and heart health.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 60 years or older.
- You have a diagnosis of heart failure with preserved ejection fraction (HFpEF), meaning your heart's pumping strength is normal but it doesn't fill properly.
- You have symptoms like breathlessness or fatigue, and you are in NYHA class II or III (moderate limitation).
- You also have a metabolic condition like high blood pressure, diabetes, or obesity, and some stomach or gut symptoms.
- Your heart failure symptoms are stable, and you have been on the same heart medications for at least a month.
- You are able to understand the study and take care of yourself independently.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether transferring healthy gut bacteria (fecal microbiota transplant) can help people with chronic heart failure feel better and improve their heart function.
This early-stage study tests whether changing the gut bacteria using an oral stool-based treatment (called oral FMT) can improve health in older adults. It aims to see if this approach affects aging-related changes, including gut and body function.
This study tests whether transferring healthy stool bacteria into your gut (called fecal microbiota transplantation) can help improve blood sugar control and heart health in people with type 2 diabetes and heart disease. It is a small, early-stage study to see if the treatment is safe and well-tolerated.
This trial studies fecal microbiota transplantation (a stool-based treatment) to improve symptoms and safety in people with certain gut and immune conditions. It aims to see whether changing gut bacteria can help you feel better.
This study tests whether transplanting healthy donor stool into the gut can help children and young adults with ongoing digestive issues after a stem cell transplant. It may improve symptoms like diarrhea or the need for feeding tubes.
This trial tests if a fecal microbiota transplant combined with nutritional support can improve chronic constipation that hasn't gotten better with standard treatments. It's a small early study to see if the approach is safe and works.
Hear when a new Chronic Heart Failure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.